Author(s):
Raj Kumari, Abhilasha Mittal, Meenakshi Sharma
Email(s):
rajkataria80@gmail.com
DOI:
10.52711/2231-5675.2024.00036 
Address:
Raj Kumari1*, Abhilasha Mittal2, Meenakshi Sharma3
1I.T.S College of Pharmacy, Murad Nagar, Ghaziabad, Uttar Pradesh.
2NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2024
ABSTRACT:
Pharmaceuticals constitute a newly recognized class of environmental poisons because of their biological activity, pseudo-persistence, and extensive use in both human and animal health. Pharmaceuticals have the potential to be toxic even at low persistence rates; these qualities, among others are what cause bioaccumulation and negative effects in both aquatic and terrestrial settings. Human pharmaceutical pollution is typically caused by trash from hospitals, homes, cities, and industries. The lack of adequately sensitive and accurate analytical techniques for detecting distinct medicines present in trace levels in the complicated matrices is a significant constraint of such investigations.
Cite this article:
Raj Kumari, Abhilasha Mittal, Meenakshi Sharma. Pharmaceutical Residues in the Environment: A Review. Asian Journal of Pharmaceutical Analysis. 2024; 14(3):201-4. doi: 10.52711/2231-5675.2024.00036
Cite(Electronic):
Raj Kumari, Abhilasha Mittal, Meenakshi Sharma. Pharmaceutical Residues in the Environment: A Review. Asian Journal of Pharmaceutical Analysis. 2024; 14(3):201-4. doi: 10.52711/2231-5675.2024.00036 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-14-3-17
10. REFERENCES:
1. Carmen LC, Mariana L, Alina ME. Pharmaceutical residues in the environment - New European Integrated Programs Required. Revista De Chimie, 2016; 67 (5); 1008-1013.
2. Pietro Bruni. Impact of Pharmaceutical Pollution on Communities and Environment in India, Published in February 2016; 1-71.
3. Larsson DGJ. Release of active pharmaceutical ingredients from manufacturing sites: need for new management strategies. Integration Environment Assessment Management. 2010; 6: 184-186 (doi:10.1002/ieam.20).
4. Holm JV, Ruegge K, Bjerg PL, Christensen TH. Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill (Grindsted, Denmark). Environment Science Technology. 1995; 29: 1415-1420 (doi:10.1021/es0005a039).
5. Grabicova K, Grabic R, Blaha M, Kumar V, Cerveny D, Fedorova G, Randak T. Presence of pharmaceuticals in benthic fauna living in a small stream affected by effluent from a municipal sewage treatment plant. Water Research. 2015; 72:145-153.
6. Daughton CG, Ruhoy IS. Environmental foot print of pharmaceuticals thesignificance of factors beyond direct excretion to sewers. Environmental Toxicology and Chemistry. 2009; 28(12): 2495-2521.
7. Richardson ML, Bowron JM. The fate of pharmaceutical chemicals in the aquatic environment. Journal of Pharmacy and Pharmacology. 1985; 37(1):1-12.
8. Sherer JT. Pharmaceuticals in the environment. American Journal of Health-System Pharmacy. 2006; 63(2): 174-178.
9. Ravisankar P, Navya CN, Pravallika D, Sri DN. A review of step-by-step analytical method validation. IOSR JPharm. 2015; 5: 7-19.
10. Mahar P, Verma A. Pharmaceutical process validation: anover view. Int J Pharm Res Bioscience. 2014; 3: 243-262.
11. Masoom RS, Zeid A. AlO th man, Nafisur R. Analytical techniques in pharmaceutical analysis: Areview. Arabian Journal of Chemistry. 2017; 10: S1409-S1421.
12. Myranda E. Pharmaceutical Waste Disposal Challenges Facing Pharmaceutical Waste Management in Healthcare. July 22, 2020.
13. Syed ZR, Ahmad ZF. Diclofenac Sensitivity to Vultures’ Death and Environmental. International Journal of Human and Health Sciences. 2019; 4(1): 19-25. Doi: http://dx.doi.org/10.31344/ijhhs.v4i1.115.
14. ICH guideline Q2(R2) on Validation of Analytical Procedures, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Pharmaceuticals for Human use, Validation of Analytical Procedures Q2(R2) Draft version Endorsed on 24 March 2022.